Gt Biopharma logo

Gt Biopharma share price today

(GTBP)

Gt Biopharma share price is $2.75 & ₹233.09 as on 14 Dec 2024, 2.30 'hrs' IST

$2.75

0.01

(0.36%)

Market is closed - opens 8 PM, 16 Dec 2024

View live Gt Biopharma share price in Dollar and Rupees. Guide to invest in Gt Biopharma from India. Also see the sentimental analysis on Indian investors investing in Gt Biopharma. Get details on the Indian mutual funds that are investing in Gt Biopharma. Get Analyst recommendations and forecasts along with all the Gt Biopharma's financials.

Gt Biopharma share price movements

  • $2.72
    $3.18

    Day's Volatility :14.47%

  • $1.92
    $10.66

    52 Weeks Volatility :81.99%

Gt Biopharma Returns

PeriodGt Biopharma IncSector (Health Care)Index (Russel 2000)
3 Months
29.86%
-9.7%
0.0%
6 Months
-6.16%
-3.4%
0.0%
1 Year
-62.96%
3.7%
0.0%
3 Years
-97.3%
3.8%
-18.9%

Gt Biopharma Key Statistics

in dollars & INR

Previous Close
$2.74
Open
$2.79
Today's High
$3.18
Today's Low
$2.7197
Market Capitalization
$6.2M
Today's Volume
$46.2K
52 Week High
$10.6599
52 Week Low
$1.9201
Revenue TTM
$0.0
EBITDA
$-6.8M
Earnings Per Share (EPS)
$-7.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-131.48%

How to invest in Gt Biopharma from India?

It is very easy for Indian residents to invest directly in Gt Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gt Biopharma stock in both rupees (INR) and dollars (USD). Search for Gt Biopharma or GTBP on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gt Biopharma or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gt Biopharma shares which would translate to 0.308 fractional shares of Gt Biopharma as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Gt Biopharma

21%

Period: Sep 14, 2024 to Dec 13, 2024. Change in 30 Days versus previous period

Search volume for Gt Biopharma on INDmoney from India has grown in the last 30 days as on Dec 14, 2024. 21% more investors are searching Gt Biopharma in the last 30 days versus the previous period.

Global Institutional Holdings in Gt Biopharma

  • DekaBank Deutsche Girozentrale

    51.69%

  • BMO Capital Markets Corp.

    1.34%

  • Bank of Montreal

    1.34%

  • Geode Capital Management, LLC

    0.67%

  • Vanguard Group Inc

    0.47%

  • Susquehanna International Group, LLP

    0.45%

Analyst Recommendation on Gt Biopharma

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Gt Biopharma(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Gt Biopharma

What analysts predicted

Upside of 300.0%

Current:

$2.75

Target:

$11.00

Insights on Gt Biopharma

  • Price Movement

    In the last 7 days, GTBP stock has moved up by 6.6%
  • GTBP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.9% return, outperforming this stock by 96.1%
  • GTBP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 31.6% return, outperforming this stock by 128.8%

Gt Biopharma Technicals Summary

Sell

Neutral

Buy

Gt Biopharma is currently in a neutral trading position according to technical analysis indicators.

Gt Biopharma Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gt Biopharma Inc
-10.46%
-6.16%
-62.96%
-97.3%
2393.18%
Regeneron Pharmaceuticals, Inc.
-7.88%
-29.12%
-13.75%
12.62%
97.06%
Biontech Se
8.26%
36.47%
18.09%
-57.96%
244.83%
Alnylam Pharmaceuticals, Inc.
-7.31%
55.92%
32.4%
28.37%
104.18%
Vertex Pharmaceuticals Incorporated
-6.16%
-2.02%
13.01%
119.83%
111.44%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gt Biopharma Inc
NA
NA
NA
0.0
-1.31
-0.61
NA
5.41
Regeneron Pharmaceuticals, Inc.
19.12
19.12
1.15
45.03
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.12
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.23
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gt Biopharma Inc
Buy
$6.2M
2393.18%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$84.9B
97.06%
19.12
33.61%
Biontech Se
Buy
$28.6B
244.83%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.8B
104.18%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
111.44%
32.84
-4.51%

About Gt Biopharma

using our proprietary platform technology, gt biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute myeloid leukemia, myeloid dysplastic syndrome, and multiple solid tumors by leveraging our proprietary nk cell engager (trike) platform technology. (nasdaq: gtbp)
Organization
Gt Biopharma
Employees
2
CEO
Mr. Michael Martin Breen
Industry
Pharmaceuticals: Other

Management People of Gt Biopharma

NameTitle
Mr. Michael Martin Breen
Interim CEO & Executive Chairman
Mr. Alan Louis Urban CPA
CFO & Secretary

Important FAQs about investing in Gt Biopharma from India :

What is Gt Biopharma share price today?

Gt Biopharma share price today stands at $2.75, Open: $2.79 ; Previous Close: $2.74 ; High: $3.18 ; Low: $2.72 ; 52 Week High: $10.66 ; 52 Week Low: $1.92. The stock opens at $2.79, after a previous close of $2.74. The stock reached a daily high of $3.18 and a low of $2.72, with a 52-week high of $10.66 and a 52-week low of $1.92.

Can Indians buy Gt Biopharma shares?

Yes, Indians can invest in the Gt Biopharma (GTBP) from India.

With INDmoney, you can buy Gt Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gt Biopharma at zero transaction cost.

How can I buy Gt Biopharma shares from India?

It is very easy to buy Gt Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gt Biopharma be purchased?

Yes, you can buy fractional shares of Gt Biopharma with INDmoney app.

What are the documents required to start investing in Gt Biopharma stocks?

To start investing in Gt Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gt Biopharma

Today’s highest price of Gt Biopharma (GTBP) is $3.18.

Today’s lowest price of Gt Biopharma (GTBP) is $2.72.

What is today's market capitalisation of Gt Biopharma

Today's market capitalisation of Gt Biopharma GTBP is 6.2M

What is the 52 Week High and Low Range of Gt Biopharma

  • 52 Week High

    $10.66

  • 52 Week Low

    $1.92

How much percentage Gt Biopharma is down from its 52 Week High?

Gt Biopharma (GTBP) share price is $2.75. It is down by 74.2% from its 52 Week High price of $10.66.

How much percentage Gt Biopharma is up from its 52 Week low?

Gt Biopharma (GTBP) share price is $2.75. It is up by 43.22% from its 52 Week Low price of $1.92.

What are the historical returns of Gt Biopharma?

  • 1 Month Returns

    -10.46%

  • 3 Months Returns

    -6.16%

  • 1 Year Returns

    -62.96%

  • 5 Years Returns

    2393.18%

Who is the Chief Executive Officer (CEO) of Gt Biopharma

Mr. Michael Martin Breen is the current Chief Executive Officer (CEO) of Gt Biopharma.